Opportunity Information: Apply for PAS 07 326
Apply for PAS 07 326
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Drug Abuse, Risky Decision Making and HIV/AIDS (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Feb 2, 2007.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Eligible applicants include: For profit organizations other than small businesses Public housing authorities/Indian housing authorities City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Small businesses County governments Independent school districts Native American tribal governments (Federally recognized) State governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal organizations (other than Federally recognized tribal governments).
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Drug Abuse, Risky Decision Making and HIV/AIDS (R03) opportunity (Funding Opportunity Number PAS-07-326) is a National Institutes of Health (NIH) small grant announcement designed to kick-start pilot and other small-scale studies that explain how drug use and addiction-related processes shape real-world decisions about risky sexual behavior. The central idea is that substance use does not only increase risk through biology or social circumstances, but also through the way it changes judgment, self-control, reward sensitivity, impulsivity, and other decision processes that can lead people toward behaviors that increase the chance of acquiring or transmitting HIV. Projects funded under this announcement are expected to keep the decision to engage in risky sexual behavior as the main focus, rather than treating sexual risk as a side outcome or secondary variable.
A defining feature of the announcement is its strong push for interdisciplinary research. NIH is explicitly encouraging applicants to combine theories and methods from fields like psychology, economics, anthropology, sociology, decision sciences, neuroscience, and computational modeling. This means proposals could range from behavioral experiments and field studies to neurocognitive work and formal models of choice, as long as they directly help explain how drug abuse or addiction mechanisms influence sexual decision making. The FOA also highlights hypothesis-driven research and modeling approaches that can generate clear, testable predictions and guide later empirical studies. In other words, the program is looking for projects that move beyond general descriptions of risk and instead identify mechanisms that can be measured, modeled, and tested.
This FOA uses the NIH Small Research Grant (R03) mechanism, which is commonly used for focused, limited-scope studies such as feasibility work, pilot data collection, secondary analyses, instrument development, or early-stage testing of novel concepts. The announcement notes that it is part of a set of parallel opportunities with the same scientific scope offered under other NIH mechanisms: PAS-07-324 (R01) for larger, full-scale projects and PAS-07-325 (R21) for exploratory/developmental research. Applicants choosing the R03 route are essentially positioning their work as smaller and tightly scoped, but still aimed at producing meaningful insight that could support larger follow-on studies.
In terms of funding, NIH estimated a total of about $2,000,000 available for projects under this FOA in fiscal year 2007. Because awards across the related R01/R21/R03 announcements can vary widely in budget size, NIH projected that the number of awards could plausibly range from as few as 5 to as many as 25, with a reasonable expectation of around 10 to 12 grants. The opportunity is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs), and it does not require cost sharing or matching.
Eligibility is broad. Applicants may include for-profit organizations (other than small businesses), small businesses, nonprofits (including both 501(c)(3) and non-501(c)(3) entities), public and private institutions of higher education, and a wide range of government entities such as state, county, city/township, special district governments, and independent school districts. Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments) are also eligible, as are public housing authorities/Indian housing authorities. The announcement further states that foreign institutions may apply, eligible federal agencies may apply, and faith-based and community-based organizations are eligible as well, making it accessible to many types of research and community partners.
Key administrative details include an original posting date of February 2, 2007, with multiple receipt dates (meaning applicants needed to follow the cycle dates specified in the full announcement rather than a single deadline). The archive date is February 2, 2010, indicating the announcement is no longer active, but it remains a useful reference for the kinds of research priorities NIH has supported in this area. The full announcement was provided through the NIH Grants Guide, and technical issues accessing it were routed to the NIH Office of Extramural Research (OER) webmaster.
Overall, PAS-07-326 targets small, rigorous studies that clarify the decision-making pathways linking drug abuse and addiction to sexual risk behavior relevant to HIV transmission, with a clear preference for interdisciplinary, mechanism-focused, and testable approaches that can build a foundation for larger research efforts.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity and its funding opportunity number?
The opportunity is titled Drug Abuse, Risky Decision Making and HIV/AIDS (R03). The Funding Opportunity Number (FOA) is PAS-07-326.
Which agency is offering this opportunity?
This is a National Institutes of Health (NIH) funding opportunity.
What is the main purpose of PAS-07-326?
The goal is to support pilot and other small-scale studies that explain how drug use and addiction-related processes influence real-world decisions about risky sexual behavior that can affect HIV acquisition or transmission.
What is the central scientific idea behind this FOA?
The FOA emphasizes that substance use may increase HIV-related sexual risk not only through biological or social pathways, but also by changing decision-making processes such as judgment, self-control, reward sensitivity, impulsivity, and related mechanisms that shape behavior.
What must projects keep as the primary focus?
Funded projects are expected to keep the decision to engage in risky sexual behavior as the main focus, rather than treating sexual risk as a secondary outcome or side variable.
What kinds of research approaches does NIH encourage under this announcement?
The FOA strongly encourages interdisciplinary research that combines theories and methods from areas such as psychology, economics, anthropology, sociology, decision sciences, neuroscience, and computational modeling.
Are hypothesis-driven studies expected?
Yes. The FOA highlights hypothesis-driven research and modeling approaches intended to generate clear, testable predictions that can guide later empirical work.
What types of study designs are consistent with this FOA?
Examples described in the announcement include behavioral experiments, field studies, neurocognitive work, and formal models of choice, as long as they directly help explain how drug abuse or addiction mechanisms influence sexual decision making.
What grant mechanism does PAS-07-326 use?
PAS-07-326 uses the NIH Small Research Grant (R03) mechanism.
What is the R03 mechanism typically used for?
The R03 mechanism is commonly used for focused, limited-scope studies such as feasibility work, pilot data collection, secondary analyses, instrument development, or early-stage testing of novel concepts.
Are there related funding opportunities with the same scientific scope?
Yes. The announcement notes parallel opportunities with the same scientific scope under other NIH mechanisms: PAS-07-324 (R01) for larger full-scale projects and PAS-07-325 (R21) for exploratory/developmental research.
How does choosing R03 position an applicant compared to R01 or R21?
Choosing the R03 route positions the project as smaller and tightly scoped, while still aiming to produce meaningful insight that could support larger follow-on studies.
How much total funding did NIH estimate for this FOA?
NIH estimated a total of about $2,000,000 available for projects under this FOA in fiscal year 2007.
How many awards were expected?
The projected number of awards could plausibly range from 5 to 25, with a reasonable expectation of around 10 to 12 grants.
What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
Is cost sharing or matching required?
No. The FOA indicates no cost sharing or matching is required.
Who is eligible to apply?
Eligibility is broad and includes for-profit organizations (other than small businesses), small businesses, nonprofits (including 501(c)(3) and non-501(c)(3) entities), public and private institutions of higher education, and many government entities (state, county, city/township, special district governments, and independent school districts).
Are tribal entities eligible?
Yes. The FOA states that Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments) are eligible.
Are public housing authorities eligible?
Yes. The announcement includes public housing authorities/Indian housing authorities as eligible applicants.
Can foreign institutions apply?
Yes. The FOA states that foreign institutions may apply.
Can federal agencies apply?
Yes. The FOA states that eligible federal agencies may apply.
Are faith-based and community-based organizations eligible?
Yes. The announcement explicitly states that faith-based and community-based organizations are eligible.
When was the FOA originally posted?
The original posting date listed is February 2, 2007.
Was there a single application deadline?
No. The FOA indicates multiple receipt dates, meaning applicants needed to follow the standard cycle dates specified in the full announcement rather than a single deadline.
Is PAS-07-326 still active?
No. The archive date is February 2, 2010, indicating the announcement is no longer active, though it remains a reference for NIH priorities in this research area.
Where was the full announcement provided?
The full announcement was provided through the NIH Grants Guide.
Who handles technical issues accessing the announcement?
The FOA notes that technical issues accessing it were routed to the NIH Office of Extramural Research (OER) webmaster.
What kinds of projects does NIH appear to prefer under this FOA?
The FOA targets small, rigorous, mechanism-focused studies that clarify the decision-making pathways linking drug abuse and addiction to sexual risk behavior relevant to HIV transmission, with a stated preference for interdisciplinary and testable approaches that can lay groundwork for larger research efforts.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Drug Abuse, Risky Decision Making and HIV/AIDS (R01)
Previous opportunity: Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 07 326
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 07 326) also looked into and applied for these:
| Funding Opportunity |
|---|
| Drug Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PAS 07 324 Funding Number: PAS 07 324 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PAS 07 325 Funding Number: PAS 07 325 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Academic Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01) Apply for PAR 07 214 Funding Number: PAR 07 214 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Education Grants in Drug Abuse and Addiction (R25) Apply for PAR 07 221 Funding Number: PAR 07 221 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Neuroscience Research on Drug Abuse (R01) Apply for PA 07 226 Funding Number: PA 07 226 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Neuroscience Research on Drug Abuse (R21) Apply for PA 07 227 Funding Number: PA 07 227 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse(R03) Apply for PA 07 228 Funding Number: PA 07 228 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Collaborative Clinical Trials in Drug Abuse (R01) Apply for PAR 07 232 Funding Number: PAR 07 232 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 07 329 Funding Number: PA 07 329 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 07 331 Funding Number: PA 07 331 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 07 330 Funding Number: PA 07 330 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R01) Apply for PA 07 333 Funding Number: PA 07 333 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R21) Apply for PA 07 334 Funding Number: PA 07 334 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Animal Models and Related Biological Materials For Research (R21) Apply for PA 07 336 Funding Number: PA 07 336 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV Treatment Adherence Research (R01) Apply for PA 07 338 Funding Number: PA 07 338 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV Treatment Adherence Research (R03) Apply for PA 07 339 Funding Number: PA 07 339 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV Treatment Adherence Research (R21) Apply for PA 07 340 Funding Number: PA 07 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developing And Improving Institutional Animal Resources (G20) Apply for PAR 07 342 Funding Number: PAR 07 342 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS Science Track Award for Research Transition (R03) Apply for PA 07 349 Funding Number: PA 07 349 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Bioengineering and Obesity (R01) Apply for PA 07 354 Funding Number: PA 07 354 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 07 326", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.